Source:http://linkedlifedata.com/resource/pubmed/id/16142670
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2005-9-5
|
pubmed:abstractText |
From the onset of the HIV/AIDS epidemic, the use of licit and illicit drugs has been investigated for its potential impact on HIV disease progression. Findings from a large number of laboratory-based studies indicate that drug abuse may exacerbate HIV disease progression; however, epidemiological studies have shown mixed results. This article presents a review of findings from both laboratory-based and epidemiologic investigations. In addition, we provide a careful evaluation of methodological strengths and limitations inherent to both study designs in order to provide a more nuanced understanding of how these findings may complement one another.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1537-6591
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
41
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1027-34
|
pubmed:meshHeading | |
pubmed:year |
2005
|
pubmed:articleTitle |
The role of substance abuse in HIV disease progression: reconciling differences from laboratory and epidemiologic investigations.
|
pubmed:affiliation |
Center for Urban Epidemiologic Studies, New York Academy of Medicine, New York 10029, USA. fkapadia@nyam.org
|
pubmed:publicationType |
Journal Article,
Review
|